Home Data Calendar Blog

SDGR

Tables

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Earnings Per Share Basic -0.43-0.860.061.81-0.39-0.56-0.67-0.48-0.43-0.49-0.49NA-0.180.06NANANA-0.26NANA
Earnings Per Share Diluted -0.41-0.860.061.75-0.39-0.56-0.67-0.48-0.43-0.49-0.49NA-0.180.05NANANA-0.26NANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Revenue From Contract With Customer Excluding Assessed Tax 74.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Revenues 74.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Cost Of Revenue 16.5818.9321.3819.0918.1419.7821.3420.6819.8118.7317.8015.9614.0410.539.5110.5510.309.259.167.74
Gross Profit 57.5523.6413.8145.6938.7017.2017.1327.9826.3611.1211.9816.1618.9915.2713.5815.6215.5310.719.8513.00
Operating Expenses 87.1779.8374.9476.1967.2463.3660.6156.6348.8845.7942.3240.0835.5830.7230.6727.4323.3722.0023.8118.62
Research And Development Expense 51.4946.8342.7040.7434.5432.8831.1227.8225.1423.2221.0921.4517.3217.0216.6613.7011.0810.359.538.44
General And Administrative Expense 25.7323.8923.2226.3123.3223.3222.0622.1317.7617.0115.8513.3913.589.739.658.946.556.468.945.09
Selling And Marketing Expense 9.959.119.029.149.387.167.436.675.975.565.385.244.673.974.364.795.745.185.345.09
Operating Income Loss -29.62-56.19-61.13-30.50-28.54-46.16-43.47-28.64-22.52-34.67-30.34-23.91-16.58-15.45-17.09-11.80-7.85-11.29-13.96-5.61
Allocated Share Based Compensation Expense 12.5312.6511.7710.8810.219.8610.439.137.467.657.024.373.003.042.731.770.580.560.530.52
Income Tax Expense Benefit -0.84-2.89-20.4326.36-0.140.190.03-0.030.27-0.000.070.070.23-0.040.060.09-0.03-0.26-0.050.05
Income Taxes Paid Net 0.631.280.830.090.330.290.130.040.210.010.100.120.160.080.090.060.050.05-0.020.06
Profit Loss -30.67-62.024.28129.14-27.21-39.86-47.67-34.45-30.71-35.01-34.97-0.52-11.593.29-4.07-14.27-7.14-11.96-0.73-5.85
Net Income Loss -30.67-62.024.28129.14-27.21-39.85-47.69-34.44-30.71-35.01-34.64-0.03-11.143.85-3.35-13.83-6.77-11.51-0.50-5.79
Comprehensive Income Net Of Tax -29.90-61.834.49130.62-25.90-40.14-48.43-36.45-31.41-35.04-34.65-0.27-11.303.60-2.18-14.28-6.78-11.50-0.48-5.78

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Assets 802.96794.15841.57838.77688.59661.99687.88719.54756.49762.62717.33744.19746.26680.12349.55349.87155.27NANANA
Liabilities 254.40230.57230.34248.51240.68198.86194.81188.87199.40182.79111.56112.41122.2449.2353.4054.3257.01NANANA
Liabilities And Stockholders Equity 802.96794.15841.57838.77688.59661.99687.88719.54756.49762.62717.33744.19746.26680.12349.55349.87155.27NANANA
Stockholders Equity 548.56563.58611.23590.26447.89463.11493.06530.67557.07579.81605.75631.77624.01630.88296.12295.52-93.36NANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Assets Current 567.80547.76591.96603.73533.99524.20556.87586.17625.06622.02649.79675.24682.98621.11307.01312.81118.54NANANA
Cash And Cash Equivalents At Carrying Value 155.31249.38285.96233.2190.47102.82127.32117.26120.27160.88117.70133.12202.30210.49110.38144.7525.99NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 161.07255.61291.02237.6995.72108.62130.82120.76123.27163.88120.70133.62202.80210.99110.88145.2526.4933.0944.4562.18
Marketable Securities Current 307.69246.91262.71294.48360.61370.74382.25408.27456.21436.31495.89515.37440.39388.49173.65143.5059.84NANANA
Accounts Receivable Net Current 65.9919.889.6546.6955.9523.5818.7729.3231.7411.3521.3611.2731.4212.2913.8516.2718.68NANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 18.15NANANA14.11NANANA12.36NANANA13.80NANANA10.56NANANA
Other Assets Noncurrent 6.017.415.076.233.312.881.801.332.853.973.382.362.352.212.102.172.34NANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Liabilities Current 133.67105.04106.80123.41108.8088.8285.5985.5391.2172.9270.3867.6273.2039.2843.0542.1745.02NANANA
Accounts Payable Current 16.8210.3212.4311.999.4710.925.269.778.088.235.967.228.404.815.526.673.52NANANA
Other Accrued Liabilities Current 12.008.547.328.565.516.409.176.897.324.837.295.722.862.202.793.193.82NANANA
Contract With Customer Liability Current 56.23NANANA57.93NANANA55.37NANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Other Liabilities Noncurrent 0.670.710.600.700.800.901.001.400.300.300.300.600.650.600.600.900.90NANANA
Operating Lease Liability Noncurrent 111.01112.72107.32104.06105.4887.1788.1177.3577.8377.146.436.847.226.767.78NA8.89NANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Stockholders Equity 548.56563.58611.23590.26447.89463.11493.06530.67557.07579.81605.75631.77624.01630.88296.12295.52-93.36NANANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 548.56563.58611.23590.26447.90463.12493.07530.67557.09579.82605.77631.78624.02630.89296.15295.55-93.32-87.25-76.55-76.66
Additional Paid In Capital Common Stock 885.97871.10856.91840.45828.70818.01807.83797.00786.96778.29769.20760.57752.56748.12417.03414.2511.65NANANA
Retained Earnings Accumulated Deficit -338.42-307.75-245.72-250.00-379.14-351.93-312.08-264.39-229.95-199.24-164.23-129.59-129.56-118.42-122.27-118.92-105.10NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax 0.28-0.49-0.68-0.90-2.38-3.69-3.40-2.66-0.650.040.080.080.320.480.73-0.440.02NANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Operating Activities -37.26-49.94-18.44-31.09-24.94-30.36-24.66-39.72-19.74-10.64-29.37-10.9243.62-12.03-9.05-5.78-11.27-5.93-4.24-4.62
Net Cash Provided By Used In Investing Activities -59.6113.2067.24172.2011.567.8434.3236.30-22.0952.3814.81-61.91-53.24-215.98-24.59-87.916.38-5.66-38.49-16.08
Net Cash Provided By Used In Financing Activities 2.331.334.520.870.480.320.400.911.221.441.643.661.43328.12-0.73212.45-1.720.2325.015.17

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Operating Activities -37.26-49.94-18.44-31.09-24.94-30.36-24.66-39.72-19.74-10.64-29.37-10.9243.62-12.03-9.05-5.78-11.27-5.93-4.24-4.62
Net Income Loss -30.67-62.024.28129.14-27.21-39.85-47.69-34.44-30.71-35.01-34.64-0.03-11.143.85-3.35-13.83-6.77-11.51-0.50-5.79
Profit Loss -30.67-62.024.28129.14-27.21-39.86-47.67-34.45-30.71-35.01-34.97-0.52-11.593.29-4.07-14.27-7.14-11.96-0.73-5.85
Depreciation Depletion And Amortization 1.351.271.171.761.141.111.130.970.650.580.730.891.010.890.880.88NANANANA
Increase Decrease In Accounts Receivable 46.1110.23-37.04-9.2632.374.82-10.55-2.9420.39-10.0110.09-20.1519.13-1.56-2.42-2.406.80-1.530.83-1.06
Increase Decrease In Accounts Payable 6.580.55-2.282.47-1.425.54-4.271.33-0.182.26-1.26-1.233.63-0.74-0.112.11-3.623.20-0.911.03
Share Based Compensation 12.5312.6511.7710.8810.219.8610.439.137.467.657.024.373.003.042.731.770.580.560.530.52

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Investing Activities -59.6113.2067.24172.2011.567.8434.3236.30-22.0952.3814.81-61.91-53.24-215.98-24.59-87.916.38-5.66-38.49-16.08
Payments To Acquire Property Plant And Equipment 2.484.922.433.581.353.001.971.700.962.782.910.510.890.330.480.840.160.290.331.06

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Financing Activities 2.331.334.520.870.480.320.400.911.221.441.643.661.43328.12-0.73212.45-1.720.2325.015.17

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Revenues 74.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Revenue From Contract With Customer Excluding Assessed Tax 74.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Operating, Drug Discovery 5.4713.665.8432.579.0212.318.4615.587.615.575.735.798.072.942.192.368.303.844.532.14
Operating, Software 68.6628.9029.3532.2147.8224.6730.0133.0838.5624.2824.0526.3424.9622.8620.9023.8117.5316.1214.4818.61
Drug Discovery 5.4713.665.8432.579.0212.318.4615.587.615.575.735.798.072.942.192.368.303.844.532.14
Hosted Software 6.015.464.454.454.123.913.603.253.092.682.702.602.372.372.312.131.931.861.911.71
On Premise Software 53.9513.8116.8119.9433.6312.5816.5921.6927.3015.5014.4517.3616.5415.0611.1115.6010.7210.308.6013.02
Professional Services 3.002.082.212.074.813.113.873.413.571.701.722.282.201.892.932.541.690.931.121.28
Software Products And Services 68.6628.9029.3532.2147.8224.6730.0133.0838.5624.2824.0526.3424.9622.8620.9023.8117.5316.1214.4818.61
Maintenance 5.695.755.885.755.255.064.954.734.614.404.184.113.843.543.553.543.183.022.852.59
Bill And Melinda Gates Foundation Trust, Related Party 0.070.060.09NA0.050.120.01NANANANANANANANANANANANANA
Structure Therapeutics, Related Party 0.210.060.07NANA0.070.07NANANANANANANANANANANANANA
US 54.5333.1323.9650.3438.7127.4727.1030.2731.9921.8219.6816.9116.3417.7713.1413.4915.6611.1510.949.87
APAC 5.695.576.24NA6.174.892.97NANANANANANANANANANANANANA
EMEA 13.723.764.83NA11.764.425.11NANANANANANANANANANANANANA
Non Us 0.190.120.163.43-9.863.653.294.192.532.542.953.142.121.852.032.441.731.191.361.76

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Expenses
Income Tax Expense Benefit
Balance Sheet
Goodwill
Assets
Goodwill
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Goodwill
Liabilities
Liabilities Current
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept